2023 Annual Conference
January 18 - 20
The Ponte Vedra Resort Lodge & Club
Ponte Vedra Beach, Fla.
All times are ET.
Thursday, January 19
U.S. Pharmaceutical Market: Trends, Issues, and Outlook
Doug Long, VP, Industry Relations, IQVIA
Doug will provide market perspective on pharmacy and pharmaceutical industry trends, issues, and forecasts for 2023 and beyond.
ASAP PDMP Standard Version 4.x: The Latest Updates to the Latest Version
Kevin Borcher, Pharm.D., Vice President, PDMP & Pharmacy Programs, CyncHealth
Development of the latest version of the ASAP Implementation Guide for Prescription Drug Monitoring Programs has been underway through 2022. With considerable stakeholder input and feedback, there have been several new fields and substantive changes to provide better reporting to PDMPs for better information to address prescription drug fraud and misuse, public health concerns and improved patient safety. Learn of the changes and the implementation timeline of the latest ASAP version.
Right Intelligence, Right Patient, Right Time
Natalie Browning, VP of Client Relations, Bamboo Health
There’s no dispute that a comprehensive and correct patient history is critical for more informed prescribing and dispensing. There’s also no debate that linking patient records across disparate systems is a complex endeavor that requires expertise in data quality assurance.
More than 43 states and territories rely on Bamboo Health — and its turnkey EHR/PMS integration — to power their prescription drug monitoring programs and ensure patient records are matched appropriately. Collectively, these clients conduct almost 6 billion API searches every year. That’s a lot of data — and a lot of opportunity for unintentional mistakes to creep into it.
But, among more than 12 million PDMP search requests processed daily on more than 2.6 billion records through Bamboo Health solutions, an analysis found just 0.03% of the 176 million patient record groups have required manual changes.
Natalie will explain how the rigor Bamboo Health deploys to ensure states and territories provide safer and more informed prescribing and dispensing. Specifically, Natalie will detail how Bamboo Health:
- Filters and cleans PDMP data to correct typos, standardize capitalization and spacing, and rectify address formatting
- Assigns multiple edges to records from unique combinations of patient identifiers and uses that data to appropriately link records.
DSCSA Supply Chain Compliance Update
Randy Hoggle, B.Pharm., Dr.P.H., M.B.A., Managing Director, Advasur, LLC
Randy Hoggle will provide an update on where the supply chain industry is on Drug Quality and Security Act (DSCSA) compliance. He will also decode what trading partners have to do to meet the new Enhanced Drug Distribution Security (EDDS) requirements, especially Interoperability.
The ABCs of Adding Pharma And OTC Media Opportunities to Your Local Pharmacy
Dan Wilmer, M.B.A., Chief Product Officer, InStep Health and Randy Mound, Pharmacy Solution Sales Specialist, IQVIA
In this session, Dan and Randy will cover common pharmaceutical and OTC media offerings in retail chain and independent pharmacies. They will also share the strategies driving these programs and offer tips for getting involved with these national promotions on a local level.
Friday, January 20
Legislative Update: What to Expect in 2023
Brad Kile, Ph.D., President, Dumbarton Group, LLC
In the wake of the 2022 elections, a new Congress convenes in January 2023 to consider a variety of legislative proposals that will impact pharmacies and the patients they serve. This program will detail critical initiatives that are moving through the legislative process in Congress and what to expect for 2023. Key issues that will be discussed include: drug pricing, PBM and health plan transparency requirements, Medicare Part D, and new reimbursement models. Participants will learn what to expect from Congress this year and how to navigate newly implemented changes.
NDC and Barcode Transformation: Impact to the Healthcare Digital Ecosystem
Melissa Sherer Krause, Pharm.D., Vice President, Pharmacy Healthcare Solutions LLC
Melissa will discuss the reasons why FDA has proposed a new format for the National Drug Code (NDC) and barcodes and provide an overview of the impact across industry, including pharma, pharmacies, payers, PBMs, wholesalers, and other stakeholders. In particular, she will address what pharmacies and pharmacy software vendors need to tackle for their operations, including risk assessment, costs, staged implementations and multiple overlapping timelines to prepare for the proposed 12-digit NDC.
Social Determinants of Health: The What, Whys and Ways Ahead
Marsha Millonig, M.B.A., B.Pharm., President and CEO , Catalyst Enterprises, LLC
Are you seeing more headlines about social determinants of health? Do you wonder what they are and why they are receiving so much attention? Social determinants of health (SDOH) are conditions in the places where people live, learn, work, and play that affect a wide range of health risks and outcomes. In this session, Marsha will discuss the five major areas that make up the social determinants of health and how they impact a person’s health and well-being. You’ll also hear about the latest ways companies and organizations are addressing SDOHs, including new approaches and innovations at both pharmacies and pharmacy technology vendors. You’ll walk away with one or more ideas that can positively impact SDOHs for your company and its stakeholders!
Doug Long, M.B.A., is vice president of industry relations at IQVIA, one the world’s largest pharmaceutical information companies. IQVIA offers services to the pharmaceutical industry in over 100 countries around the globe. Doug’s fundamental task is to help secure data for all existing and new databases supported by IQVIA, manage supplier, manufacturer and association relationships, and develop information for data partners. As a direct consequence of his involvement in these areas, Doug has considerable experience with, and a unique perspective on, the changing U.S. and global healthcare marketplace and pharmaceutical supply chain.
Kevin Borcher, Pharm.D., is vice president of PDMP and pharmacy programs at CyncHealth. In this role, he is responsible for coordinating the operations and enhancements of the PDMP and serving as the primary liaison between CyncHealth, professional associations, member organizations and stakeholders in relation to data collection, training, and publicity.
Natalie Browning is vice president of client relations at Bamboo Health. She has 20+ years of professional experience, including more than 15 years of experience in various client engagement roles at Appriss (now Bamboo Health). As vice president of customer relations, Natalie supports all efforts and activities that impact Bamboo Health’s PDMP client base. She holds a B.S. in business administration from Sullivan University.
J. Randle Hoggle, B.Pharm., D.Ph., M.B.A., is managing director of Advasur, which provides the Advasur 360 DSCSA Compliance Turn-Key Outsource System and Services for the dispenser market. Randy has over 35 years of experience in the pharmaceutical supply chain management Industry. Since 2000, Randy has founded four companies that have built four systems for the federal government with the last system being the FDA CDER Electronic Labeling Information Processing System (ELIPS), completed in 2013 as the DSQA act was passed. More recently, FDA licensed the Advasur 360 system for selected contractors to use in two studies that assessed the ability of small dispensers to comply with DSQA. Both were successfully completed with 100% compliance by the 47 small dispenser participants.
Dan Wilmer is executive vice president and chief product officer at Instep Health, where he leads product development for digital, pharmacy, and selected HCP offerings and oversees the company’s networks and analytics functions. Dan is a digital strategist and innovator with a history of building large-scale consumer health businesses. Among his past experiences, he managed the U.S. News & World Report Best Hospitals franchise, directing product development, traffic acquisition and strategy. Prior to that, Dan oversaw a portfolio of wellness sites for Everyday Health that included national personalities Jillian Michaels, Denise Austin, Joy Bauer, and Dr. Andrew Weil. He holds an M.B.A. from Columbia Business School and a B.A. from Fairfield University.
Randy Mound, B.S.P.H., R.Ph., is a pharmacy solution sales specialist for IQVIA, where his focus is on partnering with pharmacies and pharmacy software vendors to assist them with compliance, regulatory, and marketing needs. Randy received his bachelor of science in pharmacy at the University of Iowa and has held many leadership positions in the pharmacy healthcare industry over his 40+ year career. He has had experience in pharmacy operations, education, customer experience, pharmacy systems, process redesign, marketing, merchandising, and strategy.
Brad Kile, Ph.D., is president of the Dumbarton Group, LLC, where he provides services to non-profit and corporate entities to assist them in navigating health care legislative and regulatory policy changes. He is active at both the federal and state levels as an advocate in the areas of long-term care and government-funded prescription medication benefits. Brad has extensive knowledge of state-level policies and the implications of federal policies on the development and delivery of state-based health care. Brad received his Ph.D. in health care policy from the Florida State University. He earned a bachelor’s degree from James Madison University and a master’s degree from the American University in Washington, D.C.
Melissa Sherer Krause, Pharm.D., is vice president of Pharmacy Healthcare Solutions, LLC. Melissa’s areas of focus include drug compendia and classification, drug file integration in pharmacy management systems and electronic health records, pharmaceutical manufacturers’ trade channel and managed care initiatives, medication adherence, Medicare Part D operations and risk management, consumer focused education opportunities, and pharmacy school and professional association relations.
Marsha Millonig, M.B.A., B.Pharm., is the president and CEO of Catalyst Enterprises, a healthcare consulting firm dedicated to creating change. It specializes in projects that allow pharmacy, distribution, and manufacturing clients to be more efficient and value-added providers toward improved health outcomes. She is a practicing pharmacist and pharmacist immunizer, working with both independent and chain pharmacies.